Tag: Stake

Posted on

Glaxo to Hike Stake in Theravance – Zacks.com


Proactive Investors USA & Canada

Glaxo to Hike Stake in Theravance
Zacks.com
The increased holding by the pharma major reflects its confidence in the Relovair program, under which the companies are looking to replace one of Glaxo's best selling drugs Advair by evaluating treatment options for asthma and chronic obstructive …
GlaxoSmithKline Boosts Stake In Theravance To 27%RTT News
GlaxoSmithKline to Increase Its Ownership in TheravanceMarketWatch (press release)
Glaxo Lifts Theravance StakeWall Street Journal
Triangle Business Journal
all 67 news articles »

View full post on asthma – Google News

Posted on

GlaxoSmithKline Boosts Stake In Theravance To 27% – RTT News


RTT News

GlaxoSmithKline Boosts Stake In Theravance To 27%
RTT News
The move is said to be on the potential success of asthma drug Relovair, which is believed to be the successor of Seretide/Advair that logged sales of roughly $8.1 billion in 2011. Relovair is developed by Theravance and GlaxoSmithKline and is a …
GlaxoSmithKline to Increase Its Ownership in TheravanceMarketWatch (press release)
Glaxo Lifts Theravance StakeWall Street Journal
GlaxoSmithKline invests $213M in Theravance Inc.Triangle Business Journal
DailyFinance
all 48 news articles »

View full post on asthma – Google News

Posted on

GlaxoSmithKline Boosts Stake In Theravance To 27% – NASDAQ


RTT News

GlaxoSmithKline Boosts Stake In Theravance To 27%
NASDAQ
The move is said to be on the potential success of asthma drug Relovair, which is believed to be the successor of Seretide/Advair that logged sales of roughly $8.1 billion in 2011. Relovair is developed by Theravance and GlaxoSmithKline and is a …
GlaxoSmithKline to Increase Its Ownership in TheravanceMarketWatch (press release)
GlaxoSmithKline invests $213M in Theravance Inc.Triangle Business Journal
Glaxo Lifts Theravance StakeWall Street Journal
MedCity News
all 34 news articles »

View full post on asthma – Google News